Per H. Mygind, Rikke L. Fischer et al.: Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungu. In: Nature. Band 437, 2005, S. 975–980, doi:10.1038/nature04051.
T. Schneider et al.: Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall, Precursor Lipid II. In: Science. 28. Mai 2010, Band 328, Nr. 5982, S. 1168–1172, doi:10.1126/science.1185723.
Shehrazade Jekhmane, Maik G. N. Derks, Sourav Maity, Cornelis J. Slingerland, Kamaleddin H. M. E. Tehrani, João Medeiros-Silva, Vicky Charitou, Danique Ammerlaan, Céline Fetz, Naomi A. Consoli, Rachel V. K. Cochrane, Eilidh J. Matheson, Mick van der Weijde, Barend O. W. Elenbaas, Francesca Lavore, Ruud Cox, Joseph H. Lorent, Marc Baldus, Markus Künzler, Moreno Lelli, Stephen A. Cochrane, Nathaniel I. Martin, Wouter H. Roos, Eefjan Breukink, Markus Weingarth: Host defence peptide plectasin targets bacterial cell wall precursor lipid II by a calcium-sensitive supramolecular mechanism. In: Nature Microbiology. 23. Mai 2024, ISSN2058-5276, S.1–14, doi:10.1038/s41564-024-01696-9 (nature.com [abgerufen am 24. Mai 2024]).
D. Andes, W. Craig et al.: In Vivo Pharmacodynamic Characterization of a Novel Plectasin Antibiotic, NZ2114, in a Murine Infection Model. In: Antimicrobial Agents and Chemotherapy. Juli 2009, Band 53, Nr. 7, S. 3003–3009, doi:10.1128/AAC.01584-08.
Kristensen, HH et al: In Vivo Pharmacodynamic Characterization of a Novel Plectasin Antibiotic, NZ2114, in a Murine Infection Model. In: Antimicrob Agents Chemother. Band53. Jahrgang, Nr.7, 2009, S.3003–3009, doi:10.1128/AAC.01584-08, PMC 2704636 (freier Volltext).
Shehrazade Jekhmane, Maik G. N. Derks, Sourav Maity, Cornelis J. Slingerland, Kamaleddin H. M. E. Tehrani, João Medeiros-Silva, Vicky Charitou, Danique Ammerlaan, Céline Fetz, Naomi A. Consoli, Rachel V. K. Cochrane, Eilidh J. Matheson, Mick van der Weijde, Barend O. W. Elenbaas, Francesca Lavore, Ruud Cox, Joseph H. Lorent, Marc Baldus, Markus Künzler, Moreno Lelli, Stephen A. Cochrane, Nathaniel I. Martin, Wouter H. Roos, Eefjan Breukink, Markus Weingarth: Host defence peptide plectasin targets bacterial cell wall precursor lipid II by a calcium-sensitive supramolecular mechanism. In: Nature Microbiology. 23. Mai 2024, ISSN2058-5276, S.1–14, doi:10.1038/s41564-024-01696-9 (nature.com [abgerufen am 24. Mai 2024]).
nih.gov
ncbi.nlm.nih.gov
Kristensen, HH et al: In Vivo Pharmacodynamic Characterization of a Novel Plectasin Antibiotic, NZ2114, in a Murine Infection Model. In: Antimicrob Agents Chemother. Band53. Jahrgang, Nr.7, 2009, S.3003–3009, doi:10.1128/AAC.01584-08, PMC 2704636 (freier Volltext).
Shehrazade Jekhmane, Maik G. N. Derks, Sourav Maity, Cornelis J. Slingerland, Kamaleddin H. M. E. Tehrani, João Medeiros-Silva, Vicky Charitou, Danique Ammerlaan, Céline Fetz, Naomi A. Consoli, Rachel V. K. Cochrane, Eilidh J. Matheson, Mick van der Weijde, Barend O. W. Elenbaas, Francesca Lavore, Ruud Cox, Joseph H. Lorent, Marc Baldus, Markus Künzler, Moreno Lelli, Stephen A. Cochrane, Nathaniel I. Martin, Wouter H. Roos, Eefjan Breukink, Markus Weingarth: Host defence peptide plectasin targets bacterial cell wall precursor lipid II by a calcium-sensitive supramolecular mechanism. In: Nature Microbiology. 23. Mai 2024, ISSN2058-5276, S.1–14, doi:10.1038/s41564-024-01696-9 (nature.com [abgerufen am 24. Mai 2024]).
